| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.00049 | 1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.00061 | 1 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.00049 | 1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.0002 | 1 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.00017 | 1 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.00017 | 1 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.00061 | 1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.00012 | 1 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -7.7e-05 | 1 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 6.2e-05 | 1 |